Body composition, resting energy expenditure and inflammatory markers: impact in users of depot medroxyprogesterone acetate after 12 months follow-up
Open Access
- 1 February 2017
- journal article
- research article
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 61 (1) , 70-75
Abstract
Key words: Obesity; body composition; resting energy expenditure; depot medroxyprogesterone acetate; leptinKeywords
This publication has 24 references indexed in Scilit:
- National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participantsThe Lancet, 2011
- Inflammation, a Link between Obesity and Cardiovascular DiseaseMediators of Inflammation, 2010
- Variations in body mass index of users of depot-medroxyprogesterone acetate as a contraceptiveContraception, 2010
- HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: Brazilian Metabolic Syndrome Study (BRAMS)Archives of Endocrinology and Metabolism, 2009
- The Adipocyte as an Endocrine CellEndocrinology and Metabolism Clinics of North America, 2008
- Obesity and Free Fatty AcidsEndocrinology and Metabolism Clinics of North America, 2008
- Weight, fat mass, and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraceptionInternational Journal of Obesity, 2005
- Effect of menopausal status on body composition and abdominal fat distributionInternational Journal of Obesity, 2000
- Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese HumansNew England Journal of Medicine, 1996
- Progestogens and Cushing’s syndromeIrish Journal of Medical Science (1971 -), 1995